Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest & Investment Income (2016 - 2022)

Abeona Therapeutics has reported Interest & Investment Income over the past 12 years, most recently at $30000.0 for Q2 2022.

  • Quarterly results put Interest & Investment Income at $30000.0 for Q2 2022, up 275.0% from a year ago — trailing twelve months through Jun 2022 was $77000.0 (down 80.8% YoY), and the annual figure for FY2021 was $69000.0, down 94.7%.
  • Interest & Investment Income for Q2 2022 was $30000.0 at Abeona Therapeutics, up from $1000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for ABEO hit a ceiling of $652000.0 in Q1 2020 and a floor of $1000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 5 years was $156000.0 (2018), compared with a mean of $219705.9.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 2280.95% in 2018 and later crashed 97.7% in 2021.
  • Abeona Therapeutics' Interest & Investment Income stood at $533000.0 in 2018, then plummeted by 48.03% to $277000.0 in 2019, then plummeted by 85.56% to $40000.0 in 2020, then dropped by 10.0% to $36000.0 in 2021, then decreased by 16.67% to $30000.0 in 2022.
  • The last three reported values for Interest & Investment Income were $30000.0 (Q2 2022), $1000.0 (Q1 2022), and $36000.0 (Q4 2021) per Business Quant data.